Pyrotinib
Pyrotinib Uses, Dosage, Side Effects, Food Interaction and all others data.
Pyrotinib is under investigation in clinical trial NCT03756064 (Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer).
| Trade Name | Pyrotinib |
| Generic | Pyrotinib |
| Type | |
| Formula | C32H31ClN6O3 |
| Weight | Average: 583.09 Monoisotopic: 582.2146166 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Pyrotinib
